Beneficial Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Use with Control-IQ Technology in Type 2 DiabetesRoy W. Beck,Carol J. Levy,Yogish C. Kudva,Keta Pandit,Thomas Blevins,Dan Raghinaru,Jordan E. PinskerClinical Diabetes(2024)引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要